Medraysintell released its updated World Market Report and Directory on Nuclear Medicine, Edition 2015, in late June, providing a description and analysis of the latest developments in nuclear medicine. The 920-page document covers 335 radiopharmaceuticals and radionuclides and 160 companies and institutions active in nuclear medicine.

University of Southampton scientists have discovered a link between coronary heart disease and osteoporosis, suggesting both conditions could have similar causes.


Boston Scientific has initiated a worldwide study to evaluate the rate and causes of shocks for patients implanted with the Emblem subcutaneous implantable defibrillator (S-ICD). The device is indicated for primary prevention of sudden cardiac death in the setting of severely reduced cardiac function (left ventricular ejection fraction </= 35 percent).


Medtronic plc announced it has acquired the assets of Aptus Endosystems Inc., a privately held medical device company focused on developing advanced technology for endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR). Medtronic completed its acquisition of the assets of Aptus Endosystems in a transaction valued at approximately $110 million. Additional terms of the acquisition were not disclosed.


Angiography alone for procedural image guidance in the catheterization lab is sometimes not enough, and it is helpful to augment X-ray lumen imaging with intravascular ultrasound (IVUS) or optical coherence tomography (OCT) to visualize the soft tissue morphology. 

 


Key to ongoing U.S. healthcare reform are efforts to reduce costs by eliminating unnecessary medical procedures and using information technology (IT) to justify costs that are incurred to make providers more accountable. Key medical societies in each subspecialty will be responsible for what standards of care should be set and what guidelines should be followed. In the cath lab, fractional flow reserve (FFR) is already viewed as the gold standard for determining the hemodynamic impact of coronary lesions, acting as a gatekeeper to whether a patient is stented or receives medical therapy alone. For this reason, FFR is already being predicted as the measurement of record that will be required in documentation for stent reimbursement in the future. 



In recent years, there has been widespread media coverage of studies purporting to show that radiation from X-rays, computed tomography (CT) scans and other medical imaging causes cancer. But such studies have serious flaws, including their reliance on an unproven statistical model, according to a recent article in the journal Technology in Cancer Research & Treatment. Corresponding author is Loyola University Medical Center radiation oncologist James Welsh, M.D., MS.


Subscribe Now